News
News
Why IFIGENEIA Matters: YFOS
What does IFIGENEIA mean to YFOS? In this one-minute video, Theano Lampoudi shares what motivated YFOS to join the project and how IFIGENEIA supports the company's vision for innovation and technological advancement. Watch the video to hear their story.
Medical Radioisotopes Innovation in Central Macedonia
Advancing innovation in nuclear medicine, strengthening research capacity, and fostering collaboration across the health ecosystem are among the key opportunities highlighted through ongoing efforts to develop radioisotope production capabilities in Central Macedonia....
Did you know: From radium to modern cancer therapy
In the early 1900s, a cancer diagnosis often meant there was little hope. Surgery was risky, and many tumours could not be removed. Around this time, scientists like Marie Curie had discovered radium - a substance that emitted powerful, invisible radiation. Doctors...
Particle Therapy Masterclass, Greece, March 2026
The Aristotle University of Thessaloniki hosted two Particle Therapy MasterClasses PTMC carried out under the scientific coordination of Dr. Yiota Foka, physicist and researcher at GSI and CERN. It aimed to introduce students to cutting-edge developments at the...
IFIGENEIA on Bloomberg Adria: The Importance of Radioisotopes
As part of the 2nd Annual Meeting of the IFIGENEIA Project held in Ljubljana in May 2026, Dr Gorazd Drevenšek from the University of Ljubljana Faculty of Medicine and Prof. Dr Primož Pelicon from the Jožef Stefan Institute spoke to Bloomberg Adria TV about the growing...
The role of MCED tests in cancer detection
In order to increase the probability of successful cancer treatment, it is important to detect the cancer as early as possible. According to the World Health Organization (WHO) and other sources, two different methods can be distinguished for cancer detection. Early...
Why IFIGENEIA Matters: University of Sarajevo
Discover Why IFIGENEIA Matters from the perspective of the University of Sarajevo. In this one-minute video, Amer Ajanović, Emina Huko, Azra Gazibegović-Busuladžić, Adnan Beganović, Medina Dugonjić, and Naida Ustavdić share why participating in the project is...
Particle Therapy Masterclass in Greece – Online Event
A Particle Therapy MasterClass PTMC took place online in Greece on Saturday, March 28, 2026. The event was conducted entirely online, allowing participants to attend remotely. In particular, the morning programme was broadcasted live through the Veria TechLab of the...
Why IFIGENEIA Matters: Jozef Stefan Institute
Discover Why IFIGENEIA Matters from the perspective of Jožef Stefan Institute. In this one-minute video, mag. Robert Blatnik shares why participating in the project is important for the Institute and how it contributes to the project's broader vision. Watch the video...
ESRR 2026: Advances in Radiopharmacy and Radiochemistry
The 22nd European Symposium on Radiopharmacy and Radiochemistry (ESRR 2026) in Bergen, Norway (April 16-19, 2026) reinforced the critical role of radiopharmaceutical chemistry and production technologies in advancing theranostic nuclear medicine. With approximately...
Reflections from the First Year of IFIGENEIA
Progress, collaboration, and growing impact across science and society As the IFIGENEIA Project completes its first year, the project reflects on a dynamic start marked by scientific progress, growing collaboration, and increasing international visibility. Project...
Did you know: Radiofarmaceuticals and the story behind them
Radiofarmaceuticals are a special type of medicine that use radioactive substances to diagnose or treat diseases, especially cancer. But their story begins more than 100 years ago - with a surprising discovery. In 1896, the French scientist Henri Becquerel...